Literature DB >> 16860802

The umbilical coiling index and adverse perinatal outcome.

M Kashanian1, A Akbarian, J Kouhpayehzadeh.   

Abstract

OBJECTIVE: Evaluation of the relationship between umbilical coiling index (UCI) and adverse perinatal outcome.
METHOD: A prospective study was performed on 699 pregnant women who were 37-40 weeks. UCI was determined by dividing the total number of the complete vascular coiling by the total umbilical cord length in centimeters. Then the relationship between UCI and neonatal weight, amniotic fluid index, meconium, Apgar score, and fetal distress were evaluated.
RESULTS: There was a significant difference between normo- and hypocoiled groups according to the Apgar score less than 7 in minute 5, AFI<or=5; and between normo- and hypercoiled groups according to Apgar score less than 7 in minute 5, AFI<or=5, meconium, and fetal distress. Neonatal weight in normocoiled was higher than hypercoiled group. AFI<or=5, meconium and fetal distress were higher in hypercoiled than hypocoiled group. Neonatal weight in hypercoiled was less than that in the hypocoiled group, respectively.
CONCLUSION: Abnormal UCI may relate to adverse perinatal outcome.

Entities:  

Mesh:

Year:  2006        PMID: 16860802     DOI: 10.1016/j.ijgo.2006.05.029

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  3 in total

Review 1.  Umbilical cord coiling: clinical outcomes in an unselected population and systematic review.

Authors:  F A Jessop; C C Lees; S Pathak; C E Hook; N J Sebire
Journal:  Virchows Arch       Date:  2013-11-21       Impact factor: 4.064

2.  Association of coexisting morphological umbilical cord abnormality and clinical cord compromise with hypoxic and thrombotic placental histology.

Authors:  Jerzy Stanek
Journal:  Virchows Arch       Date:  2016-03-16       Impact factor: 4.064

3.  Umbilical coiling index as a marker of perinatal outcome: an analytical study.

Authors:  T Chitra; Y S Sushanth; S Raghavan
Journal:  Obstet Gynecol Int       Date:  2012-02-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.